19 drugs exempt from poison prevention packaging act

Question 1

SL nitroglycerin

Answer 1

1. Sublingual dosage forms of nitroglycerin,

Question 2

sublingual and chewable

Answer 2

Sublingual and chewable forms of isosorbide dinitrate in dosage strengths of 10 milligrams or less.

Question 3

erythromycin ethylsuccinate granules

Answer 3

Erythromycin ethylsuccinate granules for oral suspension and oral suspensions in packages containing not more than 8 grams or the equivalent of erythromycin.

Question 4

erythromysin ethylsuccinate tablets

Answer 4

Erythromycin ethylsuccinate tablets in packages containing no more than the equivalent of 16 grams erythromycin.

Question 5

anhydrous cholestyramine

Answer 5

Anhydrous cholestyramine in powder form.

Question 6

potassium supplements

Answer 6

Potassium supplements in unit dose forms, including individually wrapped effervescent tablets, unit dose vials of liquid potassium, and powdered potassium in unit dose packets, containing not more than 50 milliequivalents per unit dose.

Question 7

sodium fluoride

Answer 7

Sodium fluoride drug preparations, including liquid and tablet forms, containing no more than 264 milligrams of sodium fluoride per package.

Question 8

Betamethasone

Answer 8

Betamethasone tablets packaged in manufacturers’ dispenser packages containing no more than 12.6 milligrams betamethasone.

Question 9

mebendazole

Answer 9

Mebendazole in tablet form in packages containing not more than 600 milligrams of the drug.

Question 10

Methylprednisolone

Answer 10

Methylprednisolone in tablet form in packages containing not more than 84 milligrams of the drug.

Question 11

colestipol

Answer 11

Colestipol in powder form in packages containing not more than 5 grams of the drug.

Question 12

pancrelipase

Answer 12

Pancrelipase preparations in tablet, capsule, or powder form.

Question 13

cyclically

Answer 13

Cyclically administered oral contraceptives in mnemonic (memory-aid) dispenser packages which rely solely upon the activity of one or more progestogen or estrogen substances.

Question 14

prednisone

Answer 14

Prednisone in tablet form when dispensed in packages containing no more than 105 milligrams of the drug.

Question 15

estrogen

Answer 15

Conjugated estrogen tablets when dispensed in mnemonic dispenser packages containing not more than 32.0 milligrams of the drug.

Question 16

norethindrone

Answer 16

. Norethindrone acetate tablets in mnemonic dispenser packages containing not more than 50 milligrams of the drug.

Question 17

medroxyprogestrone

Answer 17

17. Medroxyprogesterone acetate tablets.

Question 18

sucrase

Answer 18

Sacrosidase (sucrase) preparations in a solution of glycerol and water.

Question 19

hormone replacement

Answer 19

Hormone Replacement Therapy products that rely solely upon the activity of one or more progestogen or estrogen substances.